US 6635618
Glycopeptide phosphonate derivatives
expired A61KA61K38/14A61K47/06
Quick answer
US patent 6635618 (Glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Oct 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K38/14, A61K47/06, A61K47/12, A61K47/26